Ethics and Epistemology in Big Data Research
暂无分享,去创建一个
John P A Ioannidis | Wendy Lipworth | Paul H Mason | Ian Kerridge | J. Ioannidis | I. Kerridge | P. Mason | W. Lipworth
[1] Andrei Z. Broder,et al. Big Data: New Paradigm or "Sound and Fury, Signifying Nothing"? , 2015, WSDM.
[2] Peter A. Chow-White,et al. From the bench to the bedside in the big data age: ethics and practices of consent and privacy for clinical genomics and personalized medicine , 2015, Ethics and Information Technology.
[3] John P. A. Ioannidis,et al. Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review , 2017, J. Am. Medical Informatics Assoc..
[4] J. Ioannidis. Why Most Published Research Findings Are False , 2005, PLoS medicine.
[5] Andy Podgurski,et al. Big Bad Data: Law, Public Health, and Biomedical Databases , 2013, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.
[6] Josef Korinek,et al. Proceedings of the American Society of Clinical Oncology , 1982 .
[7] D. Madigan,et al. Evaluating the impact of database heterogeneity on observational study results. , 2013, American journal of epidemiology.
[8] E. Dove,et al. What Role for Law, Human Rights, and Bioethics in an Age of Big Data, Consortia Science, and Consortia Ethics? The Importance of Trustworthiness , 2015, Laws.
[9] Nigam H. Shah,et al. The coming age of data-driven medicine: translational bioinformatics' next frontier , 2012, J. Am. Medical Informatics Assoc..
[10] S. Hoffman. The Promise and Perils of Open Medical Data. , 2016, The Hastings Center report.
[11] Lawrence Busch,et al. Big Data, Big Questions| A Dozen Ways to Get Lost in Translation: Inherent Challenges in Large Scale Data Sets , 2014 .
[12] Geoffrey S. Ginsburg,et al. Realizing the Full Potential of Precision Medicine in Health and Health Care. , 2016, JAMA.
[13] Fabian Prasser,et al. Efficient and effective pruning strategies for health data de-identification , 2016, BMC Medical Informatics and Decision Making.
[14] Magnus Rattray,et al. Making sense of big data in health research: Towards an EU action plan , 2016, Genome Medicine.
[15] E. Larson,et al. Building trust in the power of "big data" research to serve the public good. , 2013, JAMA.
[16] Peter A. Chow-White,et al. Genomic Big Data and Privacy: Challenges and Opportunities for Precision Medicine , 2016, Computer Supported Cooperative Work (CSCW).
[17] David R. Maffitt,et al. De-identification of Medical Images with Retention of Scientific Research Value. , 2015, Radiographics : a review publication of the Radiological Society of North America, Inc.
[18] Tatiana Dilla,et al. No big data without small data: learning health care systems begin and end with the individual patient , 2015, Journal of evaluation in clinical practice.
[19] Fabian Prasser,et al. The Importance of Context: Risk-based De-identification of Biomedical Data , 2016, Methods of Information in Medicine.
[20] Yael Kovo. Office of Science and Technology Policy (OSTP) , 2016 .
[21] J. Pfeifer,et al. Real‐world data in the molecular era—finding the reality in the real world , 2016, Clinical pharmacology and therapeutics.
[22] Transnational research partnerships: leveraging big data to enhance US health , 2015, Journal of Epidemiology & Community Health.
[23] Daniel J. Selcer. Ethics (review) , 2008 .
[24] Andrew Bate,et al. Designing and incorporating a real world data approach to international drug development and use: what the UK offers. , 2016, Drug discovery today.
[25] Stuart M. Speedie,et al. The value of structured data elements from electronic health records for identifying subjects for primary care clinical trials , 2015, BMC Medical Informatics and Decision Making.
[26] M. Mostert,et al. Big Data in medical research and EU data protection law: challenges to the consent or anonymise approach , 2016, European Journal of Human Genetics.
[27] James Hendler,et al. Data Integration for Heterogenous Datasets , 2014, Big Data.
[28] Bonnie Kaplan,et al. How Should Health Data Be Used? , 2016, Cambridge Quarterly of Healthcare Ethics.
[29] George Bosilca,et al. The next frontier , 1997 .
[30] Ruth Gilbert,et al. The market in healthcare data , 2015, BMJ : British Medical Journal.
[31] Jeanne Erdmann,et al. As personal genomes join big data will privacy and access shrink? , 2013, Chemistry & biology.
[32] John P. A. Ioannidis,et al. Big data meets public health , 2014, Science.
[33] Ian Scott,et al. Data Linkage: A powerful research tool with potential problems , 2010, BMC health services research.
[34] Abraham L. Newman. What the “right to be forgotten” means for privacy in a digital age , 2015, Science.
[35] Marcel Salathé,et al. Ethical Challenges of Big Data in Public Health , 2015, PLoS Comput. Biol..
[36] Bartha M Knoppers,et al. An ethics safe harbor for international genomics research? , 2013, Genome Medicine.
[37] Jamie Cattell,et al. How big data can revolutionize pharmaceutical R & D April 2013 , 2013 .
[38] J. Ioannidis,et al. Clinical Genomics: From Pathogenicity Claims to Quantitative Risk Estimates. , 2016, JAMA.
[39] Anthony N. Nguyen,et al. De-identification of health records using Anonym: Effectiveness and robustness across datasets , 2014, Artif. Intell. Medicine.
[40] José A. Sacristán Md PhD Medical Director and. No big data without small data: learning health care systems begin and end with the individual patient , 2015 .
[41] J. Ioannidis,et al. Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey , 2016, British Medical Journal.
[42] Abraham Verghese,et al. Evolutionary Pressures on the Electronic Health Record: Caring for Complexity. , 2016, JAMA.
[43] Mikko Niemi,et al. Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1 , 2013, Genome Medicine.
[44] Türkay Dereli,et al. Big Data and Ethics Review for Health Systems Research in LMICs: Understanding Risk, Uncertainty and Ignorance—And Catching the Black Swans? , 2014, The American journal of bioethics : AJOB.
[45] David Meyre,et al. From big data analysis to personalized medicine for all: challenges and opportunities , 2015, BMC Medical Genomics.
[46] J. Avorn,et al. A review of uses of health care utilization databases for epidemiologic research on therapeutics. , 2005, Journal of clinical epidemiology.
[47] Darcy A. Davis,et al. Bringing Big Data to Personalized Healthcare: A Patient-Centered Framework , 2013, Journal of General Internal Medicine.
[48] K. Fiedler. Voodoo Correlations Are Everywhere—Not Only in Neuroscience , 2011, Perspectives on psychological science : a journal of the Association for Psychological Science.
[49] Melanie Swan,et al. The Quantified Self: Fundamental Disruption in Big Data Science and Biological Discovery , 2013, Big Data.
[50] Kate M. Miltner,et al. Big Data| Critiquing Big Data: Politics, Ethics, Epistemology | Special Section Introduction , 2014 .
[51] F. Collins,et al. A new initiative on precision medicine. , 2015, The New England journal of medicine.
[52] John P. A. Ioannidis,et al. Routinely collected data and comparative effectiveness evidence: promises and limitations , 2016, Canadian Medical Association Journal.
[53] J. Vockley,et al. Precision medicine in the age of big data: The present and future role of large‐scale unbiased sequencing in drug discovery and development , 2016, Clinical pharmacology and therapeutics.
[54] D. Strech,et al. Collective agency and the concept of ‘public’ in public involvement: A practice-oriented analysis , 2016, BMC Medical Ethics.
[55] J. Ioannidis,et al. What Happens When Underperforming Big Ideas in Research Become Entrenched? , 2016, JAMA.
[56] Katherine Bourzac. Collaborations: Mining the motherlodes , 2015, Nature.
[57] D. Lazer,et al. The Parable of Google Flu: Traps in Big Data Analysis , 2014, Science.
[58] Aryya Gangopadhyay,et al. A data recipient centered de-identification method to retain statistical attributes , 2014, J. Biomed. Informatics.
[59] John P. A. Ioannidis,et al. Systematic assessment of pharmaceutical prescriptions in association with cancer risk: a method to conduct a population-wide medication-wide longitudinal study , 2016, Scientific Reports.
[60] Viju Raghupathi,et al. Big data analytics in healthcare: promise and potential , 2014, Health Information Science and Systems.
[61] Stephen Fenlon,et al. The anaesthetist and the Medicines and Healthcare products Regulatory Agency , 2012 .
[62] S. Hoffman. Electronic Health Records and Research: Privacy Versus Scientific Priorities , 2010, The American journal of bioethics : AJOB.
[63] D. Madigan,et al. Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership , 2012, Statistics in medicine.
[64] Eneida A. Mendonça,et al. Genetic data and electronic health records: a discussion of ethical, logistical and technological considerations , 2013, J. Am. Medical Informatics Assoc..
[65] D. Boyd,et al. CRITICAL QUESTIONS FOR BIG DATA , 2012 .
[66] Heikki Joensuu,et al. Comparison of solution-based exome capture methods for next generation sequencing , 2011, Genome Biology.
[67] J Ferguson,et al. The next frontier: Fostering innovation by improving health data access and utilization , 2015, Clinical pharmacology and therapeutics.
[68] J. Ioannidis,et al. Collaborative Cancer Epidemiology in the 21st Century: The Model of Cancer Consortia , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[69] Luciano Floridi,et al. The Ethics of Big Data: Current and Foreseeable Issues in Biomedical Contexts , 2015, Science and Engineering Ethics.
[70] Raymond K. Auerbach,et al. The real cost of sequencing: higher than you think! , 2011, Genome Biology.
[71] Jocelyn Kaiser,et al. BIOMEDICAL RESOURCES. Funding for key data resources in jeopardy. , 2016, Science.
[72] Cornelius Puschmann,et al. Big Data, Big Questions| Metaphors of Big Data , 2014 .
[73] John P A Ioannidis,et al. Informed Consent, Big Data, and the Oxymoron of Research That Is Not Research , 2013, The American journal of bioethics : AJOB.
[74] A. Docherty,et al. Big Data – ethical perspectives , 2014, Anaesthesia.
[75] J. Ioannidis,et al. Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies. , 2014, American journal of epidemiology.
[76] I. Kerridge,et al. More Than One Way to Be Global: Globalization of Research and the Contest of Ideas , 2016, The American journal of bioethics : AJOB.
[77] Timothy Caulfield,et al. Biotechnology and the popular press: hype and the selling of science. , 2004, Trends in biotechnology.
[78] John P A Ioannidis,et al. Design and analysis of metabolomics studies in epidemiologic research: a primer on -omic technologies. , 2014, American journal of epidemiology.
[79] Liam Peyton,et al. A unified framework for evaluating the risk of re-identification of text de-identification tools , 2016, J. Biomed. Informatics.
[80] John P A Ioannidis,et al. Assessment of vibration of effects due to model specification can demonstrate the instability of observational associations. , 2015, Journal of clinical epidemiology.
[81] B. Knoppers,et al. Ethics review for international data-intensive research , 2016, Science.
[82] Eric Bender,et al. Big data in biomedicine: 4 big questions , 2015, Nature.
[83] Markus Christen,et al. Ethical Challenges of Simulation-Driven Big Neuroscience , 2016 .
[84] J. Ioannidis. Microarrays and molecular research: noise discovery? , 2005, The Lancet.
[85] Derek C Angus,et al. Fusing Randomized Trials With Big Data: The Key to Self-learning Health Care Systems? , 2015, JAMA.
[86] D. Roden,et al. Integrating electronic health record genotype and phenotype datasets to transform patient care , 2016, Clinical pharmacology and therapeutics.
[87] A. Butte,et al. Leveraging big data to transform target selection and drug discovery , 2016, Clinical pharmacology and therapeutics.
[88] J. Ioannidis,et al. Current use of routinely collected health data to complement randomized controlled trials: a meta-epidemiological survey. , 2016, CMAJ open.
[89] Tomasz Janowski,et al. Interoperability in Big, Open, and Linked Data--Organizational Maturity, Capabilities, and Data Portfolios , 2014, Computer.
[90] T. Murdoch,et al. The inevitable application of big data to health care. , 2013, JAMA.
[91] Gang-hoon Kim,et al. Potentiality of Big Data in the Medical Sector: Focus on How to Reshape the Healthcare System , 2013, Healthcare informatics research.
[92] Charles Auffray,et al. Participatory medicine: a driving force for revolutionizing healthcare , 2013, Genome Medicine.
[93] Pam Carter,et al. The social licence for research: why care.data ran into trouble , 2015, Journal of Medical Ethics.
[94] J. Ioannidis,et al. Epidemiologic design and analysis for proteomic studies: a primer on -omic technologies. , 2015, American journal of epidemiology.
[95] P. Brown,et al. Balancing Benefits and Risks of Immortal Data: Participants' Views of Open Consent in the Personal Genome Project. , 2016, The Hastings Center report.
[96] E. Schadt. The changing privacy landscape in the era of big data , 2012, Molecular systems biology.
[97] Nicolas P Terry. Big data proxies and health privacy exceptionalism. , 2014, Health matrix.
[98] P. Rothwell. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation , 2005, The Lancet.
[99] K. Brothers,et al. Clinical decision-making and secondary findings in systems medicine , 2016, BMC Medical Ethics.
[100] Peter J. Tonellato,et al. Scalable and cost-effective NGS genotyping in the cloud , 2015, BMC Medical Genomics.
[101] David W Bates,et al. Integrating Predictive Analytics Into High-Value Care: The Dawn of Precision Delivery. , 2016, JAMA.
[102] Lee Murray,et al. The 100,000 Genomes Project , 2015 .
[103] Mark A. Rothstein,et al. Ethical Issues in Big Data Health Research: Currents in Contemporary Bioethics , 2015, Journal of Law, Medicine & Ethics.
[104] Rick Howard. Big data hype cut down to size , 2013 .
[105] Melnned M. Kantardzic. Big Data Analytics , 2013, Lecture Notes in Computer Science.
[106] Jill U. Adams,et al. Genetics: Big hopes for big data , 2015, Nature.
[107] Nicolas P. Terry,et al. Protecting Patient Privacy in the Age of Big Data , 2012 .
[108] Werner Callebaut,et al. Scientific perspectivism: A philosopher of science's response to the challenge of big data biology. , 2012, Studies in history and philosophy of biological and biomedical sciences.
[109] A. Terzic,et al. Big Data Transforms Discovery–Utilization Therapeutics Continuum , 2016, Clinical pharmacology and therapeutics.
[110] Henri-Corto Stoeklé,et al. 23andMe: a new two-sided data-banking market model , 2016, BMC Medical Ethics.
[111] Leo Anthony Celi,et al. A “datathon” model to support cross-disciplinary collaboration , 2016, Science Translational Medicine.
[112] Thomas Ploug,et al. Meta consent: a flexible and autonomous way of obtaining informed consent for secondary research , 2015, BMJ : British Medical Journal.
[113] Jon R Lorsch,et al. Perspective: Sustaining the big-data ecosystem , 2015, Nature.
[114] Kenneth Goossens,et al. Monitoring laboratory data across manufacturers and laboratories--A prerequisite to make "Big Data" work. , 2015, Clinica chimica acta; international journal of clinical chemistry.
[115] I. Kohane,et al. Finding the missing link for big biomedical data. , 2014, JAMA.
[116] Joachim Roski,et al. Creating value in health care through big data: opportunities and policy implications. , 2014, Health affairs.
[117] Alexander Heintzel. Realizing the Full Potential , 2018 .
[118] G. Wayne Clough,et al. Office of Science and Technology Policy Hearing Welcome Remarks , 1999 .
[119] Fabrício F. Costa. Big data in biomedicine. , 2014, Drug discovery today.